🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Pleased to share our INTEGRIS-PSC data as a late-breaker presentation as part of the 75th anniversary of The Liver Meeting® hosted by AASLD in San Diego November 15-19, 2024. Details: lnkd.in/ghH4quDp #TLM24 #TheLiverMeeting #LiverTwitter

In honor of #HispanicHeritageMonth and #filipinoamericanhistory Month, our Plianteers joined forces with LifeMoves and Life Science Cares to create inspirational cultural arts and craft kits for the resident families in LifeMoves interim housing units. #FAHM #TeamPliant

Join Pliant team members as they sit for a #firesidechat with Stifel Financial Corp. analyst, Alex Thompson, PhD, as part of the Stifel 2024 #Healthcare Conference on Tuesday, November 19th. More details: ir.pliantrx.com/news-releases/…

Today we provided a company update and announced our Third Quarter 2024 Financial Results. Review our 2024 progress and 2025 near-term milestones: ir.pliantrx.com/news-releases/…

We are pleased to present clinical data from our bexotegrast program at @AASLD’s The Liver Meeting 2024. To review our oral and poster presentations please visit: ir.pliantrx.com/news-releases/… #TLM24 #AASLD #primarysclerosingcholangitis

Throughout December members of our team will be participating in events hosted by Evercore ISI, Citi, Piper Sandler and Oppenheimer & Co. Inc. to share our progress with the investment community. More details: ir.pliantrx.com/news-releases/…

This Thanksgiving week, we’re reminded of the incredible community that surrounds us. This year, Team Pliant joined Pulmonary Fibrosis Foundation Walks nationwide to raise funds and awareness for pulmonary fibrosis. Together, we're working to bring hope to patients impacted by fibrotic diseases.

We’re feeling grateful for the unwavering dedication of our employees, patients, advocacy partners, clinicians, and all who work tirelessly alongside us to advance our mission. Collectively, we share a vision of improving patient's lives. Wishing everyone a Happy Thanksgiving!

We’re proud to be working with Black Health Matters in support of BEACON-IPF initiatives aimed to enhance diversity in our clinical trials & expand outreach to the Black and African American communities. Looking forward to the year ahead. Learn more: beaconipf.com

Giving back is part of our core at Pliant & we’re delighted to support HealthRIGHT 360’s Women’s Recovery Association program by donating holiday self-care kits. We recognize the importance of making a difference in our communities! Learn more: healthright360.org #givingback

With 2024 coming to a close, we reflect on the progress made in advancing our mission to make a difference in the lives of patients impacted by fibrotic diseases. We look forward to an exciting 2025. From all of us at Pliant, wishing you & your loved ones a happy holiday season!

Join our CEO, Dr. Bernard Coulie, at the 43rd Annual J.P. Morgan Healthcare Conference with a review of our 2024 achievements and 2025 milestones in a presentation on Tuesday, January 14 at 1:30 p.m. PT. #JPM25 #JPMHC25 ir.pliantrx.com/news-releases/…

We’re hiring! Looking to make a difference in patients’ lives and work alongside an incredible team? Join #TeamPliant in the fight against fibrotic diseases. Explore open positions on our careers page. pliantrx.com/jobs/ #Hiring #BiotechJobs #TeamPliant

We’re thrilled to welcome Dr. Delphine Imbert as our new Chief Technical Officer! She brings a wealth of experience in CMC technical operations and joins at a pivotal time as we advance bexotegrast towards commercialization. Learn more about Dr. Imbert: ir.pliantrx.com/news-releases/…

Happy New Lunar Year! Today, we celebrated the Year of the Snake with a special lunch, bringing our team together to enjoy delicious Chinese cuisine & embracing the unique stories that enrich our workplace culture. Wishing everyone wisdom, growth, and prosperity! #YearOfTheSnake

Today we announced our Fourth Quarter 2024 Financial Results and provided a company update. Read press release here: ir.pliantrx.com/news-releases/…

We are pleased to announce interim data from our Phase 1 trial of PLN-101095 in patients with immune checkpoint inhibitor- refractory advanced or metastatic solid tumors. Read the press release here: ir.pliantrx.com/news-releases/…

Today, we announced three upcoming presentations at the American Thoracic Society's 2025 International Conference, taking place May 16-21 in San Francisco, California. Read the press release here: ir.pliantrx.com/news-releases/… #ATS2025 American Thoracic Society (ATS)

Today, we announced our First Quarter 2025 Financial Results and provided a company update. Read press release here: ir.pliantrx.com/news-releases/…

A productive week at the American Thoracic Society (ATS)'s 2025 International Conference featured pre-clinical and clinical work from our teams. Learn more and access the presentation and posters ir.pliantrx.com/news-releases/… #ATS2025